Veoza, also known as fezolinetant, will be offered to women for whom HRT is unsuitable
More than 500,000 women in England are to be offered a drug on the NHS that prevents hot flushes.
The green light for Veoza, also known as fezolinetant, comes after the medicines watchdog, the National Institute for Health and Care Excellence, on Wednesday authorised it for use.
